Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies

NCT03248479 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
258
Enrollment
INDUSTRY
Sponsor class

Stopped This study has been discontinued due to futility based on the results of a planned analysis of the ENHANCE trial.

Conditions

Interventions

Sponsor

Gilead Sciences